Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
Inova Health System · Inova Fairfax Hospital · +1 more institution
Abstract
UNLABELLED: Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver disease worldwide. We estimated the global prevalence, incidence, progression, and outcomes of NAFLD and nonalcoholic steatohepatitis (NASH). PubMed/MEDLINE were searched from 1989 to 2015 for terms involving epidemiology and progression of NAFLD. Exclusions included selected groups (studies that exclusively enrolled morbidly obese or diabetics or pediatric) and no data on alcohol consumption or other liver diseases. Incidence of hepatocellular carcinoma (HCC), cirrhosis, overall mortality, and liver-related mortality were determined. NASH required histological diagnosis. All studies were reviewed by three independent investigators.…
Citation impact
- FWCI
- 228.11
- Percentile
- 100%
- References
- 31
Authors
6Topics & keywords
- Medicine
- Internal medicine
- Nonalcoholic fatty liver disease
- Metabolic syndrome
- Epidemiology
- Gastroenterology
- Incidence (geometry)
- Fatty liver
- Good health and well-being